Document is current
Any future updates will be listed below
-
Authors
Johansson, Emily White https://orcid.org/0000-0001-5162-8277
Linde, Mattias
Ohlis, Anna
Mattsson, Mathias
Shaaban, Ahmed Nabil
Gustafsson, Sofie
Holm, Johan
Dalman, Christina
Agardh, Emilie E.
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 19 January 2026
First Online: 23 February 2026
Declarations
:
: Ethical approvals for this study were received from the Swedish Ethical Review Authority (DNR: 2018/1339-31/5, 2018/2292-32, 2019–02185, 2021 − 00657 and 2022-03111-02, 2023-07509-02.2018/1339-31/5, 2018/2292-32, 2019–02185, 2021 − 00657, 2022-03111-02, 2023-07509-02, 2024-02816-02).
: Not applicable.
: JH and SG are employees and stock owners at Pfizer. ML has received honoraria from Abbvie, Lundbeck, Novartis, Pfizer, TEVA, and holds a patent related to a biofeedback intervention for migraine prophylaxis, Coinventor. No other competing interests have been declared.
